{"DataElement":{"publicId":"2741589","version":"1","preferredName":"During Collection Hematopoietic Stem Cell Graft Combined Other Anticoagulant Agent Administration Therapies Specify","preferredDefinition":"The free-text field to describe other anticoagulants that were added to the hematopoietic cell graft during collection.","longName":"D_C_HSC_OTH_ANCO_SPE","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2741573","version":"1","preferredName":"During Collection Hematopoietic Stem Cell Graft Combined Other Anticoagulant Agent Administration","preferredDefinition":"At some point in a given period of time._The act of gathering things together; having been brought together in one place._Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)_Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body._Made or joined or united into one or involving the joint activity of two or more._Different than the one(s) previously specified or mentioned._A drug that helps prevent blood clots from forming. Also called a blood thinner._The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","longName":"D_CO_HSC_OT_ANCO_ADM","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2794370","version":"1","preferredName":"During Collection Hematopoietic Stem Cell Graft","preferredDefinition":"At some point in a given period of time.:The act of gathering something together.:Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.):Healthy skin, bone, or other tissue taken from one part of the body and used to replace diseased or injured tissue removed from another part of the body.","longName":"C25490:C25453:C12551:C12981","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"During","conceptCode":"C25490","definition":"At some point in a given period of time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Collection","conceptCode":"C25453","definition":"The act of gathering things together; having been brought together in one place.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Hematopoietic Stem Cell","conceptCode":"C12551","definition":"Primitive blood cells derived from embryonic mesenchyme capable of differentiating into any of the blood cell line progenitor cells (erythroblasts, young granulocytic series cells, megakaryocytes, etc.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Graft","conceptCode":"C12981","definition":"Tissue or organ transplanted from a donor to a recipient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"59CB36D3-7CEB-63FD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-10-21","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-10-21","modifiedBy":"ONEDATA","dateModified":"2008-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2743401","version":"1","preferredName":"Combined Other Anticoagulant Agent Administration","preferredDefinition":"Made or joined or united into one or involving the joint activity of two or more.:Not otherwise specified.:Agents that prevent blood clotting. Naturally occurring agents in the blood are included only when they are used as drugs.:The act of administration.","longName":"C25454:C17649:C263:C25409","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Combined","conceptCode":"C25454","definition":"Made or joined or united into one or involving the joint activity of two or more.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Anticoagulant Agent","conceptCode":"C263","definition":"Any agent capable of preventing blood clot formation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administration","conceptCode":"C25409","definition":"The act of the dispensing, applying, or tendering of something to another, such as administration of a medicine.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B288EBF-2109-4059-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-18","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-18","modifiedBy":"ONEDATA","dateModified":"2008-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AEBFB94-1CC4-571F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018810","version":"1","preferredName":"Therapies Specify","preferredDefinition":"the free text field related to therapy.","longName":"TX_SPEC","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2184338","version":"1","preferredName":"Specify","preferredDefinition":"Specify; be specific about something; define clearly.","longName":"Specify","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB6C8AC6-2084-3E75-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-05-27","endDate":null,"createdBy":"SBREXT","dateCreated":"2004-05-27","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B9BA236E-6B3E-350B-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-01-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-03-25","modifiedBy":"CAMPBELB","dateModified":"2008-03-28","changeDescription":"released as entered during ISO compliance update","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2695319","version":"1","longName":"NMDP: CDEs to review","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"2964920","version":"1","longName":"2006r1: HSCT Infusion","context":"NHLBI"},{"publicId":"3191905","version":"1","longName":"2007r1:Cord Blood Unit -SCTOD Data Requirements","context":"NHLBI"}]},{"publicId":"3553940","version":"1","longName":"BRIDG","context":"NHLBI","ClassificationSchemeItems":[{"publicId":"4133055","version":"1","longName":"Version 3.2","context":"NHLBI"}]},{"publicId":"6685474","version":"1","longName":"Artificial Neural Network Algorithm for BRIDG Mapping","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6685476","version":"1","longName":"Training Set","context":"NCIP"}]}],"AlternateNames":[{"name":"inf_antcoag_oth_prod_spec","type":"NMDP_FN","context":"NHLBI"},{"name":"MaterialName:name ","type":"HCT_BRIDG","context":"NHLBI"}],"ReferenceDocuments":[{"name":"Specify the other anticoagula","type":"Preferred Question Text","description":"Specify the other anticoagulants","url":null,"context":"NHLBI"},{"name":"BRIDG mapping path for CDE:2741589","type":"BRIDG Mapping Path","description":"PerformedSubstanceAdministration > Product [stem cells] > Subject [stem cells] > PerformedProcedure > Product [additive] > MaterialName.name WHERE PerformedSubstanceAdministration > DefinedSubstanceAdministration = \"Perform Overall hematopoitic stem cell transplantation\" AND Product.typeCode [StemCells] = \"stem cells\" AND Product.typeCode [additive] = \"anticoagulant\" AND PerformedProcedure > DefinedProcedure.nameCode = \"process hematopoitic stem cell transplantation product\"","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"4AED3131-D2DE-6134-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-15","endDate":null,"createdBy":"ZHANGW","dateCreated":"2008-04-15","modifiedBy":"KUMMEROA","dateModified":"2021-06-21","changeDescription":". 2021-6-21 ak System generated def displayed as alt def.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}